A class action lawsuit launched in Auckland today questioning Johnson and Johnson cold and flu products follows similar suits worldwide.

JGA Saddler has filed a suit in the High Court, claiming the producer knowingly sold an ineffective product.

The US Food and Drug Administration has ruled a key ingredient in Codral, Sudafed, and Benadryl cold and flu products is ineffective when taken orally.

JGA Saddler director, Rebecca Jancauskas says it's sparked a wave of legal action.

"Our firm filed a claim in Australia, in December. A Canadian firm filed a class-action about 12 months ago, and there's also quite a number of claims on foot in America." 

LISTEN ABOVE

A class action lawsuit launched in Auckland today questioning Johnson and Johnson cold and flu products follows similar suits worldwide.
JGA Saddler has filed a suit in the High Court, claiming the producer knowingly sold an ineffective product.
The US Food and Drug Administration has ruled a key ingredient in Codral, Sudafed, and Benadryl cold and flu products is ineffective when taken orally.
JGA Saddler director, Rebecca Jancauskas says it's sparked a wave of legal action.
"Our firm filed a claim in Australia, in December. A Canadian firm filed a class-action about 12 months ago, and there's also quite a number of claims on foot in America."&nbsp;
LISTEN ABOVE

With a straight down the middle approach, Heather du Plessis-Allan Drive on Newstalk ZB delivers the very latest news and views to New Zealanders as they wrap up their day.

Heather du Plessis-Allan Drive

Rebecca Jancauskas: JGA Saddler director on the lawsuit launched against ‘ineffective’ cold and flu medications

https://api.omny.fm/orgs/7784f840-c291-422a-924b-ad9000bbad71/clips/be78c572-baef-4389-aa2e-b2830052942b/transcript